GSK1292263
GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. Phase 2.
| Trivial name | N/A |
| Catalog Number | S2149 |
| Molecular Formula | C25H20N4O2S2 |
| CAS# | 1032823-75-8 |
| Inchi | InChI=1S/C25H20N4O2S2/c30-22(28-21-12-11-18(15-26-21)17-7-3-1-4-8-17)16-33-25-27-20-13-14-32-23(20)24(31)29(25)19-9-5-2-6-10-19/h1-12,15H,13-14,16H2,(H,26,28,30) |
| Inchi Key | QESQGTFWEQMCMH-UHFFFAOYSA-N |
| SMILES | C1CSC2=C1N=C(N(C2=O)C3=CC=CC=C3)SCC(=O)NC4=NC=C(C=C4)C5=CC=CC=C5 |
| Size | 10mg |
| Supplier Page | http://www.selleckchem.com/products/GSK1292263.html |
| Additional Information | https://file.selleck.cn/downloads/struct/GSK-1292263-chemical-structure-S2149.gif |